Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 160Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3APOTEX INC

02 3NOVARTIS PHARMACEUTICALS CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

OXCARBAZEPINE

Brand Name : APO-OXCARBAZEPINE

Dosage Form : TABLET

Dosage Strength : 150MG

Packaging : 100

Approval Date :

Application Number : 2284294

Regulatory Info : Prescription

Registration Country : Canada

blank

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

OXCARBAZEPINE

Brand Name : APO-OXCARBAZEPINE

Dosage Form : TABLET

Dosage Strength : 300MG

Packaging : 100

Approval Date :

Application Number : 2284308

Regulatory Info : Prescription

Registration Country : Canada

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

OXCARBAZEPINE

Brand Name : APO-OXCARBAZEPINE

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 100

Approval Date :

Application Number : 2284316

Regulatory Info : Prescription

Registration Country : Canada

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

OXCARBAZEPINE

Brand Name : TRILEPTAL 300 MG

Dosage Form : TABLET

Dosage Strength : 300MG

Packaging : 50

Approval Date :

Application Number : 2242068

Regulatory Info : Prescription

Registration Country : Canada

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

OXCARBAZEPINE

Brand Name : TRILEPTAL 600 MG

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 50

Approval Date :

Application Number : 2242069

Regulatory Info : Prescription

Registration Country : Canada

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

OXCARBAZEPINE

Brand Name : TRILEPTAL ORAL SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 60MG/ML

Packaging : 250 ML

Approval Date :

Application Number : 2244673

Regulatory Info : Prescription

Registration Country : Canada

blank